Direct in vivo evaluation of tumor VEGFR in response to treatment with pazopanib: A novel molecular imaging study.

3049 Background: Several small molecule tyrosine kinase inhibitors (TKI) targeting VEGFR are already approved for use in anti- angiogenic therapy either alone or in combination with chemotherapeuti...